ABCB1 and myeloid leukemia: Recently, we have reported that K562/ADR cells, a DOX-resistant derivative of human myeloid leukemia K562 cells, had decreased N-glycan bisection and an increased expression of a drug efflux transporter, P-glycoprotein, compared to parental K562 cells.